Search
for
Sort by
Research 301–330 of 1000+
- Obesity and the Polycystic Ovary Syndrome
- Dermoscopy of skin infestations and infections (entomodermoscopy) – Part I: dermatozoonoses and bacterial infections
- Physiological perspective of Hirsutism in Unani Medicine: An Overview and Update
- Serum Vitamin D Level in Pediatric Alopecia Areata
- THE MULTIFACETED APPROACH TO POLYCYSTIC OVARIAN SYNDROME: A REVIEW OF TRADITIONAL AND ALLOPATHIC MEDICINE
- Minoxidil oral en alopecias no androgénicas
- The Case Files
- Botanical Treatment for Polycystic Ovary Syndrome
- Comparison of Efficacy of Various Modalities of Treatment in Patients with Androgenetic Alopecia
- YKL-40 a sensitive biomarker for early androgenetic alopecia and early hidden metabolic syndrome
- Understanding Polycystic Ovary Syndrome
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- Pharmacology of anabolic steroids
- The Rotterdam Study: 2016 objectives and design update
- Polycystic Ovary Syndrome
- The PDGF/PDGFR pathway as a drug target
- Telogen effluvium
- Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
- Protoporphyrin IX: the Good, the Bad, and the Ugly
- Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Dermatologic manifestations of endocrine disorders
- Methotrexate in dermatology
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
- Advancements and challenges in stem cell transplantation for regenerative medicine
- Hyperaldosteronism and Hyperprogesteronism in a Cat
- 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes